相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Poly(ADP-ribose) polymerase inhibition prevents reactive oxygen species induced inhibition of aldehyde dehydrogenase2 activity
Shu-jian Wei et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Poly(ADP-ribose) polymerase 1 inhibition protects against low shear stress induced inflammation
Wei-dong Qin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Poly(ADP-ribose) polymerase-1-induced NAD+ depletion promotes nuclear factor-κB transcriptional activity by preventing p65 de-acetylation
Tiina M. Kauppinen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
LOX-1 in atherosclerosis: biological functions and pharmacological modifiers
Suowen Xu et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Vascular Smooth Muscle Cell Sirtuin 1 Protects Against DNA Damage and Inhibits Atherosclerosis
Isabelle Gorenne et al.
CIRCULATION (2013)
Enhanced NF-κB Activity Impairs Vascular Function Through PARP-1-, SP-1-, and COX-2-Dependent Mechanisms in Type 2 Diabetes
Modar Kassan et al.
DIABETES (2013)
Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
Reza Sharifi et al.
EMBO JOURNAL (2013)
PARP inhibitors: polypharmacology versus selective inhibition
Torun Ekblad et al.
FEBS JOURNAL (2013)
Seven sirtuins for seven deadly diseases of aging
Brian J. Morris
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Poly (ADP-ribose) polymerase 14 and its enzyme activity regulates TH2 differentiation and allergic airway disease
Purvi Mehrotra et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes
Caries Canto et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Macrodomain-containing proteins are new mono-ADP-ribosylhydrolases
Florian Rosenthal et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
A family of macrodomain proteins reverses cellular mono-ADP-ribosylation
Gytis Jankevicius et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Negative regulation of inflammation by SIRT1
Jun Xie et al.
PHARMACOLOGICAL RESEARCH (2013)
Identification of Pim Kinases as Novel Targets for PJ34 with Confounding Effects in PARP Biology
Albert A. Antolin et al.
ACS CHEMICAL BIOLOGY (2012)
Poly(ADP-ribose) polymerase 1 inhibition protects human aortic endothelial cells against LPS-induced inflammation response
Xiaonu Peng et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2012)
Inflammation in Atherosclerosis
Peter Libby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
The diverse roles and clinical relevance of PARPs in DNA damage repair: Current state of the art
Mike De Vos et al.
BIOCHEMICAL PHARMACOLOGY (2012)
The NAD+ Precursor Nicotinamide Riboside Enhances Oxidative Metabolism and Protects against High-Fat Diet-Induced Obesity
Caries Canto et al.
CELL METABOLISM (2012)
The Role of PARP-1 and PARP-2 Enzymes in Metabolic Regulation and Disease
Peter Bai et al.
CELL METABOLISM (2012)
Poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein
Magdolna Szanto et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
SIRT1: new avenues of discovery for disorders of oxidative stress
Zhao Zhong Chong et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2012)
Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes
Peter Bai et al.
FEBS LETTERS (2012)
Poly(ADP-Ribose) Polymerase 1 Inhibition Improves Coronary Arteriole Function in Type 2 Diabetes Mellitus
Soo-Kyoung Choi et al.
HYPERTENSION (2012)
Inflammasome-Activated Caspase 7 Cleaves PARP1 to Enhance the Expression of a Subset of NF-κB Target Genes
Sueheda Erener et al.
MOLECULAR CELL (2012)
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors
Elisabet Wahlberg et al.
NATURE BIOTECHNOLOGY (2012)
Reanalysis of phosphoproteomics data uncovers ADP-ribosylation sites
Ivan Matic et al.
NATURE METHODS (2012)
Quantitative proteomics profiling of the poly(ADP-ribose)-related response to genotoxic stress
Jean-Philippe Gagne et al.
NUCLEIC ACIDS RESEARCH (2012)
SIRTUIN 1 AND SIRTUIN 3: PHYSIOLOGICAL MODULATORS OF METABOLISM
Ruben Nogueiras et al.
PHYSIOLOGICAL REVIEWS (2012)
Age-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue
Hassina Massudi et al.
PLOS ONE (2012)
Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Marie-France Langelier et al.
SCIENCE (2012)
Tanshinone II-A inhibits oxidized LDL-induced LOX-1 expression in macrophages by reducing intracellular superoxide radical generation and NE-κB activation
Suowen Xu et al.
TRANSLATIONAL RESEARCH (2012)
Targeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
Carles Canto et al.
PHARMACOLOGICAL REVIEWS (2012)
Interference between PARPs and SIRT1: a novel approach to healthy ageing?
Carles Canto et al.
AGING-US (2011)
Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in Apolipoprotein-E knockout mice fed a high cholesterol diet
Suowen Xu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Minocycline reduces plaque size in diet induced atherosclerosis via p27Kip1
Khurrum Shahzad et al.
ATHEROSCLEROSIS (2011)
iNOS induction and PARP-1 activation in human atherosclerotic lesions: an immunohistochemical and ultrastructural approach
Ida Perrotta et al.
CARDIOVASCULAR PATHOLOGY (2011)
Poly(ADP-ribose) polymerase-2 depletion reduces doxorubicin-induced damage through SIRT1 induction
Magdolna Szanto et al.
CARDIOVASCULAR RESEARCH (2011)
Loss of Tankyrase-Mediated Destruction of 3BP2 Is the Underlying Pathogenic Mechanism of Cherubism
Noam Levaot et al.
CELL (2011)
Crosstalk between Components of Circadian and Metabolic Cycles in Mammals
Gad Asher et al.
CELL METABOLISM (2011)
PARP-2 Regulates SIRT1 Expression and Whole-Body Energy Expenditure
Peter Bai et al.
CELL METABOLISM (2011)
PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
Peter Bai et al.
CELL METABOLISM (2011)
The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
Shahneen K. Sandhu et al.
CURRENT DRUG TARGETS (2011)
Mass spectrometry-based functional proteomics of poly(ADP-ribose) polymerase-1
Emilie Pic et al.
EXPERT REVIEW OF PROTEOMICS (2011)
PARP-14 Functions as a Transcriptional Switch for Stat6-dependent Gene Activation
Purvi Mehrotra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Sirtuins at a glance
Takashi Nakagawa et al.
JOURNAL OF CELL SCIENCE (2011)
Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway
Fu-qiang Liu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Sirtuins, Aging, and Medicine
Leonard Guarente
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Age Related Changes in NAD plus Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats (Publication with Expression of Concern. See vol. 17, 2022)
Nady Braidy et al.
PLOS ONE (2011)
Poly(ADP-ribose) Polymerase 1 Is Indispensable for Transforming Growth Factor-β Induced Smad3 Activation in Vascular Smooth Muscle Cell
Dan Huang et al.
PLOS ONE (2011)
Non-antibacterial tetracyclines modulate mediators of periodontitis and atherosclerotic cardiovascular disease: A mechanistic link between local and systemic inflammation
Ying Gu et al.
PHARMACOLOGICAL RESEARCH (2011)
Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease
Travis J. Bench et al.
PHARMACOLOGICAL RESEARCH (2011)
Cellular and cytokine-based inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis
Peter J. Little et al.
PHARMACOLOGY & THERAPEUTICS (2011)
Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1-Dependent Cell Death (Parthanatos)
Yingfei Wang et al.
SCIENCE SIGNALING (2011)
The potential for poly (ADP-ribose) polymerase inhibitors in cancer therapy
M. Javle et al.
Therapeutic Advances in Medical Oncology (2011)
PARP INHIBITION IN ATHEROSCLEROSIS AND ITS EFFECTS ON DENDRITIC CELLS, T CELLS AND AUTO-ANTIBODY LEVELS
C. Erbel et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2011)
Regulation of SIRT1 in cellular functions: Role of polyphenols
Sangwoon Chung et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2010)
Opposing roles of PARP-1 in MMP-9 and TIMP-2 expression and mast cell degranulation in dyslipidemic dilated cardiomyopathy
Chetan P. Hans et al.
CARDIOVASCULAR PATHOLOGY (2010)
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
Carles Canto et al.
CELL METABOLISM (2010)
The Secret Life of NAD+: An Old Metabolite Controlling New Metabolic Signaling Pathways
Riekelt H. Houtkooper et al.
ENDOCRINE REVIEWS (2010)
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
Sokrates Stein et al.
EUROPEAN HEART JOURNAL (2010)
Serum or target deprivation-induced neuronal death causes oxidative neuronal accumulation of Zn2+ and loss of NAD+
Christian T. Sheline et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2010)
Conserved role of SIRT1 orthologs in fasting-dependent inhibition of the lipid/cholesterol regulator SREBP
Amy K. Walker et al.
GENES & DEVELOPMENT (2010)
Mechanical stretch enhances NF-κB-dependent gene expression and poly(ADP-ribose) synthesis in synovial cells
Toshiaki Morisugi et al.
JOURNAL OF BIOCHEMISTRY (2010)
Identification of the Aryl Hydrocarbon Receptor Target Gene TiPARP as a Mediator of Suppression of Hepatic Gluconeogenesis by 2,3,7,8-Tetrachlorodibenzo-p-dioxin and of Nicotinamide as a Corrective Agent for This Effect
Silvia Diani-Moore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism
Bhaskar Ponugoti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Poly(ADP-Ribose) Polymerase-1 Is a Determining Factor in Crm1-Mediated Nuclear Export and Retention of p65 NF-κB upon TLR4 Stimulation
Mourad Zerfaoui et al.
JOURNAL OF IMMUNOLOGY (2010)
Genetic Ablation of PARP-1 Protects Against Oxazolone-Induced Contact Hypersensitivity by Modulating Oxidative Stress
Attila Brunyanszki et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Effect of an Antimicrobial Agent on Atherosclerotic Plaques Assessment of Metalloproteinase Activity by Molecular Imaging
Satoru Ohshima et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Inflammatory and age-related pathologies in mice with ectopic expression of human PARP-1
Aswin Mangerich et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2010)
Investigation of PARP-1, PARP-2, and PARG interactomes by affinity-purification mass spectrometry
Maxim Isabelle et al.
PROTEOME SCIENCE (2010)
Toward a unified nomenclature for mammalian ADP-ribosyltransferases
Michael O. Hottiger et al.
TRENDS IN BIOCHEMICAL SCIENCES (2010)
Poly(ADP-ribose) polymerase-1 (PARP-1) and its therapeutic implications
Rupinder K. Sodhi et al.
VASCULAR PHARMACOLOGY (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
Poly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging
Matthias Altmeyer et al.
AGING-US (2009)
Inhibition of matrix metalloproteinase-2 by PARP inhibitors
Adrian C. Nicolescu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Poly (ADP-ribose) Polymerase Inhibition Improves Endothelial Dysfunction Induced by Hyperhomocysteinemia in Rats
Xian Yu et al.
CARDIOVASCULAR DRUGS AND THERAPY (2009)
Reduced Apoptosis and Plaque Necrosis in Advanced Atherosclerotic Lesions of Apoe-/- and Ldlr-/- Mice Lacking CHOP
Edward Thorp et al.
CELL METABOLISM (2009)
Pharmacotherapy of coronary atherosclerosis
Aloke V. Finn et al.
EXPERT OPINION ON PHARMACOTHERAPY (2009)
Poly (ADP-Ribose) Polymerase Inhibition Attenuates Atherosclerotic Plaque Development in ApoE-/- Mice with Hyperhomocysteinemia
Jiang-jiao Xie et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2009)
Poly(ADP-Ribose) Polymerase Mediates Inflammation in a Mouse Model of Contact Hypersensitivity
Peter Bai et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Thieno[2,3-c]Isoquinolin-5-one, a Potent Poly(ADP-Ribose) Polymerase Inhibitor, Promotes Atherosclerotic Plaque Regression in High-Fat Diet-Fed Apolipoprotein E-Deficient Mice: Effects on Inflammatory Markers and Lipid Content
Chetan P. Hans et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
A randomized, placebo-controlled trial to evaluate the tolerability, safety, pharmacokinetics, and pharmacodynamics of a potent inhibitor of poly(ADP-ribose) polymerase (INO-1001) in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of the TIMI 37 trial
David A. Morrow et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2009)
SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1
Senthilkumar B. Rajamohan et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Carles Canto et al.
NATURE (2009)
Nicotinamide Prevents NAD+ Depletion and Protects Neurons Against Excitotoxicity and Cerebral Ischemia: NAD+ Consumption by SIRT1 may Endanger Energetically Compromised Neurons
Dong Liu et al.
NEUROMOLECULAR MEDICINE (2009)
Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites
Matthias Altmeyer et al.
NUCLEIC ACIDS RESEARCH (2009)
Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE-/- Mice: Effects on eNOS and Oxidative Stress
Chetan P. Hans et al.
PLOS ONE (2009)
Combining affinity purification by ADP-ribose-binding macro domains with mass spectrometry to define the mammalian ADP-ribosyl proteome
Nadia Dania et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Role of the peroxynitrite-poly(ADP-ribose) polymerase pathway in human disease
Pal Pacher et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Preventing NAD(+) Depletion Protects Neurons against Excitotoxicity Bioenergetic Effects of Mild Mitochondrial Uncoupling and Caloric Restriction
Dong Liu et al.
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Activation and Overexpression of PARP-1 in Circulating Mononuclear Cells Promote TNF-α and IL-6 Expression in Patients with Unstable Angina
Dan Huang et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
Differential effects of PARP inhibition on vascular cell survival and ACAT-1 expression favouring atherosclerotic plaque stability
Chetan P. Hans et al.
CARDIOVASCULAR RESEARCH (2008)
Heart disease and stroke statistics - 2008 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2008)
Hyperelongated biglycan: the surreptitious initiator of atherosclerosis
Peter J. Little et al.
CURRENT OPINION IN LIPIDOLOGY (2008)
Poly (ADP) ribose synthetase inhibition in alveolar macrophages undergoing hypoxia and reoxygenation
Anton S. McCourtie et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2008)
Inhibition of the activity of poly (ADP-ribose) polymerase reduces heart ischaemia/reperfusion injury via suppressing JNK-mediated AIF translocation
Zhao-Feng Song et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Poly (ADP-ribose) polymerases (PARPs) 1-3 regulate astrocyte activation
Nirmal K. Phulwani et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Regulation of transcription factor NFAT by ADP-ribosylation
Opeyemi A. Olabisi et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Regulation of NFAT by poly (ADP-ribose) polymerase activity in T cells
Rut Valdor et al.
MOLECULAR IMMUNOLOGY (2008)
Toward specific functions of poly(ADP-ribose) polymerase-2
Jose Yelamos et al.
TRENDS IN MOLECULAR MEDICINE (2008)
PARP1 is required for adhesion molecule expression in atherogenesis
Tobias von Lukowicz et al.
CARDIOVASCULAR RESEARCH (2008)
The macroPARP genes Parp-9 and Parp-14 are developmentally and differentially regulated in mouse tissues
Antoinette Hakme et al.
DEVELOPMENTAL DYNAMICS (2008)
Peroxisome proliferator-activated receptor (PPAR)-2 controls adipocyte differentiation and adipose tissue function through the regulation of the activity of the retinoid x receptor/PPARγ heterodimer
Peter Bai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Subendothelial lipoprotein retention as the initiating process in atherosclerosis -: Update and therapeutic implications
Ira Tabas et al.
CIRCULATION (2007)
Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by hypochlorite
Tamas Radovits et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
Csaba Szabo et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Poly(ADP-ribose) polymerase inhibition improves endothelial dysfunction induced by reactive oxidant hydrogen peroxide in vitro
Tamas Radovits et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice -: Effects on macrophage recruitment, nuclear factor-κB nuclear translocation, and foam cell death
Karine Oumouna-Benachour et al.
CIRCULATION (2007)
Prolonged poly(ADP-ribose) polymerase-1 activity regulates JP-8-induced sustained cytokine expression in alveolar macrophages
Luis A. Espinoza et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Nitric oxide and peroxynitrite in health and disease
Pal Pacher et al.
PHYSIOLOGICAL REVIEWS (2007)
Novel modulators of poly(ADP-ribose) polymerase
Csaba Szabo et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Regulation of SIRT 1 mediated NAD dependent deacetylation: A novel role for the multifunctional enzyme CD38
Pinar Aksoy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy
Jyothish B. Pillai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
PARP-2 deficiency affects the survival of CD4+CD8+ double-positive thymocytes
Jose Yelamos et al.
EMBO JOURNAL (2006)
Immunomodulatory effects of poly(ADP-ribose)polymerase inhibition contribute to improved cardiac function and survival during acute cardiac rejection
Gabor Szabo et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2006)
Minocycline inhibits poly(ADP-ribose) polymerase-1 at nanomolar concentrations
Conrad C. Alano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Poly(ADP-ribose)-polymerase-catalyzed hydrolysis of NAD+:: QM/MM simulation of the enzyme reaction
Daniele Bellocchi et al.
CHEMMEDCHEM (2006)
Insulin resistance and atherosclerosis
J Nigro et al.
ENDOCRINE REVIEWS (2006)
Activation of the peroxynitrite-poly(adenosine diphosphate-ribose) polymerase pathway during neointima proliferation:: A new target to prevent restenosis after endarterectomy
CJ Beller et al.
JOURNAL OF VASCULAR SURGERY (2006)
In silico characterization of the family of PARP-like poly(ADP-ribosyl) transferases (pARTs) -: art. no. 139
H Otto et al.
BMC GENOMICS (2005)
Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors
P Jagtap et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Defective transcription factor activation for proinflammatory gene expression in poly(ADP-ribose) polymerase 1-deficient glia
HC Ha
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial
DL Brown et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Attenuation of neointima formation through the inhibition of DNA repair enzyme PARP-1 in balloon-injured rat carotid artery
CX Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells
JR Revollo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase
R Benkö et al.
LIFE SCIENCES (2004)
Activator protein-1 signalling pathway and apoptosis are modulated by poly(ADP-ribose) polymerase-1 in experimental colitis
B Zingarelli et al.
IMMUNOLOGY (2004)
Transcription regulation of TNF-alpha-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells
A Carrillo et al.
NUCLEIC ACIDS RESEARCH (2004)
A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging
P Pacher et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Poly(ADP-Ribose) polymerase inhibition prevents homocysteine-induced endothelial dysfunction in the isolated rat aorta
A Tasatargil et al.
PHARMACOLOGY (2004)
Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?
J Zhang
BIOESSAYS (2003)
Functional interaction between PARP-1 and PARP-2 in chromosome stability and embryonic development in mouse
JMN de Murcia et al.
EMBO JOURNAL (2003)
Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms
MW Manning et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Poly(ADP-ribose) polymerase inhibitors
GJ Southan et al.
CURRENT MEDICINAL CHEMISTRY (2003)
Coenzymatic activity of randomly broken or intact double-stranded DNAs in auto and histone H1 trans-poly(ADP-ribosylation), catalyzed by poly(ADP-ribose) polymerase (PARP I)
E Kun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase novel therapeutic approach rase may represent a in chronic heart failure
P Pacher et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
The therapeutic potential of poly(ADP-ribose) polymerase inhibitors
L Virág et al.
PHARMACOLOGICAL REVIEWS (2002)
The functional role of poly(ADP-ribose)polymerase 1 as novel coactivator of NF-κB in inflammatory disorders
PO Hassa et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2002)
Elevated levels of oxidative DNA damage and DNA repair enzymes in human atherosclerotic plaques
W Martinet et al.
CIRCULATION (2002)
Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1
V Schreiber et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages
H Yamaguchi et al.
INFECTION AND IMMUNITY (2002)
Poly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in glia
HC Ha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury
MP Bendeck et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation
P Pacher et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
The enzymatic and DNA binding activity of PARP-1 are not required for NF-κB coactivator function
PO Hassa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Rapid reversal of the diabetic endothelial dysfunction by pharmacological inhibition of poly(ADP-ribose) polymerase
FG Soriano et al.
CIRCULATION RESEARCH (2001)
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
FG Soriano et al.
NATURE MEDICINE (2001)
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes
HH Parving et al.
DIABETES CARE (2001)
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
S Imai et al.
NATURE (2000)
Oxidative stress and nuclear factor-kappa B activation - A reassessment of the evidence in the light of recent discoveries
A Bowie et al.
BIOCHEMICAL PHARMACOLOGY (2000)
分享论文
